Switching Between GLP-1 Drugs During a Shortage
Pharmaceutical availability gaps are still affecting patients across the US. This page provides the latest information on availability and alternatives.
Stock Status
Based on the latest data, supply conditions for semaglutide and tirzepatide products is highly variable by:
- Specific medication and strength: Initial titration doses are frequently in better supply than target doses
- Geographic location: Distribution networks send more stock to major metro regions while less populated regions see more shortages
- Where you fill: Mail-order options occasionally access products not in chain supply
Individual Dose Status
Initial Titration Strengths
Initial titration products are generally easier to find because:
- A smaller population remains on initial dosing long-term
- Manufacturers prioritize initial supply to ensure onboarding capability
Higher Dosing
Maintenance strengths face more pressure because:
- Most patients end up on maintenance dosing and remain
- Manufacturing lags behind with growing demand
Action Plan
Immediate Steps
- Phone before visiting — never drive to the store before verifying availability
- Check several pharmacies — call at least 5 locations not just chains
- Ask about waiting lists — some locations will call when stock arrives
If You Can’t Find It
- Contact your doctor about alternative dosing — a doctor can authorize dose splitting
- Ask about 503B pharmacy products — if the drug is formally listed, compounded versions are legally available
- Contact the drug maker — pharma companies have programs to locate medication
Where to Track
Check these sources to keep current:
- FDA.gov shortage page — the official record
- Manufacturer websites — availability information straight from the source
- Your pharmacy app — may display whether it’s in stock
- Online forums — other patients post current availability intel
New data is added regularly.